Prevention committee

ESGO Prevention 1

The ESGO Prevention Committee is a group of field experts and their research teams, working in the prevention of gynaecological cancers with geographical representation across Europe.

Established in 2019 to fulfil the ESGO vision: Best treatment and prevention in gynaecological cancer, the ESGO Prevention Committee connects more than 70 experts in vaccination, screening, colposcopy, and treatment of pre-invasive disease.

Apart from scientific work, the Prevention Committee also organises webinars & virtual conferences on prevention-related topics. Visit the ESGO Prevention Webinars website to learn more about the webinars we organise.

Prof. Murat Gultekin chairs the Committee.

Committee Motto

  • Filling the scientific gap by providing scientific evidence on topics related to prevention and treatment of pre-invasive disease
  • Bridging the East and the West by sharing the expertise of ESGO professionals with colleagues in Lower and Middle Income Countries via virtual conferences, webinars, and on-site screening pilot projects

Committee Goals

  • Facilitate systematic research, issue scientific publications, and disseminate findings in the prevention and treatment of pre-invasive diseases.
  • Raise public and governmental awareness and advocate about gynaecological cancers, their prevention and treatment through ENGAGe.
  • Collaborate with professional societies, patient advocacy organisations, policymakers and other stakeholders to advance gynaecological cancers prevention and care.
  • Contribute to cervical cancer elimination in Europe in line with the WHO elimination programme 2030. Decrease mortality and extend life of gynaecological cancer patients in line with the EU Beat the cancer plan.

Committee Structure

Prevention Committee Chair: Murat Gultekin

 

 

 

 

 

 

Prevention Committee Members:

Frederic Amant, Marc Arbyn, Nicolo Bizzarri, Daniela Fisherova, Mihaela Grigore, Elmar Joura, Vesna Kesic, Maria Kyrgiou, Claudia Marchetti, Zoltan Novak, Mario Preti, Jalid Sehouli, Nikolaos Thomakos, Ignacio Zapardiel

Patient expert: Icó Tóth

Prevention network:

Utku Akgor, Nagham Abraheem Mahdi, Henri Azais, Esat Bilal, Federica Bevilacqua, Sarah Bowden, Laia Bruni, Laura Burney Ellis, Murat Cengiz, Kimon Chatzistamatiou, Volkan Hasan Ege, Houssein El Hajj, Niccolo Gallio, Omar Gassama, Livia Giordano, Charlotte Goutallier, Dimitrios Haidopulos, Houssein El Hajj, Reda Hemida, Ermina Iljazovic, Nicolo Gallio, , Joana Kacperczyk-Bartnik, André Boris Kind, Belen Lopez, Edina Lukacs, Nermean Mostafa, Anita Mitra, Nagham Ibraheem Mahdi, Afraa Mahjoob Al-Naddawi, Gadelkareem Nassar, Sara Nasser, Vasilios Pergialiotis, Milena Perišič, Patrick Petignat, Alejandra Picconi, Jurgen Piek, Deepali Raina, Sofia Raposo, Eva-Maria Niine-Roolaht,  Zoia Razumova, Jalid Sehouli, Aleksandra Shavrova, Rita Sousa, Alexndra Strojna, Nadja Taumberger, Vasilios Theodoulidis, Charalampos Theofanakis, Andreas Ullrich, Zvi Vaknin, Alexandra Wagner, Ignacio Zapardiel

The ESGO Prevention network is open to all experts in the field. If you would like to be a part of it and shape the future scientific and educational projects within ESGO, sign up!

Join the ESGO Prevention Network

 

Committee Publications

Publications 2025
Publications 2025

  • Prediction of Treatment Failure After Excisional Treatment of Cervical Precancer: A Systematic Review and Meta-analysis, M. Arbyn et. al., published in the Green Journal, September 2025

  • Implementing High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer Screening in Ghana: A Study (CarciSCAN) Protocol, N. Taumberger et. al., published in Cancer Control, April 2025

  • Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement, M. Kyrgiou et. al., published in Lancet Oncology, March 2025

  • Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) consensus statement, M. Preti et. al., published in International Journal of Gynecologic Cancers, January 2025
Publications 2024
Publications 2023
Publications 2022
Publications 2021
Publications 2020
Publications 2019

Visit the ESGO Prevention Webinars website to learn more about the webinars we organise.

All Prevention Committee webinars are available on the eAcademy portal

Click on the link to see them all.

Cooperation with key stakeholders

 

World Health Organization has launched ''Cervical Cancer Elimination Program'' on November 19, 2020.

The program asks the countries to vaccinate the girls under 15 years of age (90% coverage), to screen females by minimal two times when they are 35 and 45 (70%) coverage and to treat the lesions detected appropriately (in 90% of cases).

Modelling studies show that if all countries can implement the program until 2030 and can achieve these targets, there will be a 30% reduction in cervical cancer mortality by 2030 and the cervical cancer may be eliminated until the end of this century (namely incidence less than 4 \ 100.000).

 

ESGO Prevention committee has joined in to fulfil the WHO cervical cancer elimination strategy as a leading European actor in prevention.

European projects

RISCC: Risk-based Screening for Cervical Cancer

ESGO/ENGAGe is involved in the Horizon 2020 RISCC project.

Within the RISCC project ESGO / ENGAGe is responsible for the co-creation of the e-health/m-health platform for risk based cervical cancer screening and for the dissemination of the results to 12 ENGAGe member countries. This project is planned for five years and intended to terminate in 2025.

For more information about the ESGO/ENGAGe involvement please use the following link.

Prevention webinars

All Prevention Committee webinars are available for free on the eAcademy portal.

Subscribe to the ESGO Prevention newsletter

Latest research:

Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement

Read article

Maria Kyrgiou, et. al., published in Lancet Oncology in March 2025

 

Implementing High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer Screening in Ghana: A Study (CarciSCAN) Protocol

Read article

N. Taumberger et. al., published in Cancer Control in April 2025

Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) consensus statement

Read article

 M. Preti et. al., published in the International Journal of Gynecologic Cancers in January 2025

As a part of the Vulvar inspection manuscript, several educational materials were developed: